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LEGISLATION AND GENETIC DISCRIMINATION
SHARONA HOFFMAN1
I will be talking about the laws that address genetic discrimination, and there is quite
a variety of them. Let me begin with state laws.
I. STATE LEGISLATION
State legislation addresses genetic discrimination in both employment and health
insurance. Thirty-one states have passed laws that address genetic discrimination in
employment. Approximately thirteen states prohibit employers from requiring
applicants to undergo genetic testing as a condition of employment. Some states
have more limited restrictions. Florida prohibits only the screening of applicants for
the sickle-cell trait. Wisconsin requires employers to obtain written and informed
consent from applicants prior to administering genetic tests, but does not preclude
their utilization altogether. Some states establish exceptions that permit genetic
testing that is job-related or that is conducted, with the employee’s written and
informed consent, for the purpose of investigating Workers’ Compensation claims or
to protect the employee’s health by testing for potential work-related medical
problems.
Some employees actually wish to undergo genetic testing to determine if they
have genetic conditions such as chronic berrylium disease, which is triggered by
exposure to toxins in the workplace. I have read that a few employees have filed
claims against their employers for not conducting this kind of genetic testing. The
issue of genetic testing can therefore be a “catch 22” for employers. Many
employees will be upset if the employer subjects them to genetic tests because they
believe the tests constitute an invasion of privacy. Others, however, will accuse the
employer of misconduct if the employer does not offer genetic testing that will detect
susceptibility to a condition that is triggered by a known substance in the workplace.
Let us turn to health insurance. As of 1999, over half the states had enacted laws
prohibiting health insurance companies from requiring genetic testing as a condition
of coverage or from denying insurance or charging higher rates based upon the
results of genetic tests. Again, the statutes vary in their breadth and scope. The
Texas statute, for example, applies only to group health benefits plans and not to
individual health insurance policies. The Alabama statute pertains only to genetic
tests for cancer.
Even the statutes that address the discriminatory use of all genetic test results
may leave many individuals unprotected. One problem that drafting legislation
presents is the challenge of crafting language that is precise enough to be sufficiently
inclusive. This is particularly difficult when it comes to discussing new technology,
such as genetic testing. “Genetic test” is typically defined as “A laboratory test of
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human chromosomes or DNA that is used to identify the presence or absence of
inherited or congenital alterations in genetic material that are associated with disease
or illness.” Under this definition, an insurer would violate the law if it discriminated
against an individual based on a physical DNA test, but not if it discriminated based
on a family history of genetic abnormalities, such as a parent’s death from
Huntington’s disease. A better, more inclusive approach is to prohibit discrimination
based on any “genetic information,” which would include information derived from
family histories. A few states have adopted this approach, and in the employment
arena, several states specifically prohibit employers from attaining genetic data
concerning the applicant’s family members.
The state laws are largely inconsistent in their scope, and therefore, the degree of
protection one enjoys may depend on the state of one’s residence. Another
limitation of the state statutes is that they do not apply to self-funded employer plans.
Under the Employee Retirement Security Act of 1974 (ERISA),2 state laws
regulating health insurance, including those that prohibit discrimination, are
preempted by ERISA insofar as they apply to self-funded employee benefit plans.
An increasing number of employers, especially large employers, are self-insured.
Employees who obtain insurance through these self-insured employers are not
protected by the state laws that prohibit genetic discrimination. Consequently, the
regulation of insurers’ use of genetic information cannot be left to the states alone.
II. HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA)
Significant protection is provided by the Health Insurance Portability and
Accountability Act of 1996 (HIPAA).3 HIPAA mandates that group health plans
may not establish rules for enrollment eligibility based on “genetic information.” So,
for example, if there is a group seeking health insurance, the insurer cannot refuse to
insure particular members of the group because of genetic information.
HIPAA also requires that all group health plans limit to no more than twelve
months their period of excluded coverage for pre-existing conditions; that is,
conditions for which medical advice, diagnosis, care, or treatment was recommended
or received in the prior six months. HIPAA provides, however, that genetic
information may not be considered a preexisting condition “in the absence of a
diagnosis of the condition relating to such information.” Thus, a woman who
undergoes genetic testing and tests positive for BRCA1,4 which indicates that she is
at an increased risk of breast cancer, may not be excluded from coverage for breast
cancer for any period of time unless she has actually been diagnosed with the
disease. These mandates, however, apply only to group health plans and therefore
do not protect the 10 to 15 percent of the insured who have individual policies.
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III. AMERICANS WITH DISABILITIES ACT (ADA)
The second federal law that is relevant to the issue of genetic discrimination is
the Americans with Disabilities Act (ADA).5 The ADA prohibits employers from
discriminating against qualified individuals with disabilities with respect to a variety
of employment activities, such as hiring, promotion, firing, and benefits of
employment, including insurance. Employers cannot refuse to hire or fire someone
because of her disability, and they cannot provide inferior insurance benefits or no
benefits to an individual because she has a disability. So, the question is: Does the
ADA protect people who don’t have a disability but who have a genetic abnormality
that might lead to a disability in the future?
The ADA covers individuals who have a “physical or mental impairment that
substantially limits one or more of [their] major life activities.”6 This provision does
not apply to discrimination based solely on the results of a genetic test. Someone
who is asymptomatic but tests positive for the BRCA1 abnormality and therefore has
over a 50 percent chance of developing breast cancer in the future is not currently an
individual with an actual disability. The ADA also protects those who have a
“record of” a disability.7 This is also inapplicable to an asymptomatic person who
tests positive for the BRCA1 abnormality, because she has not developed the disease
and therefore has no record of suffering from a disability. Finally, the ADA protects
individuals who don’t have a disability but who are incorrectly “regarded as” having
a disability, and this is the most relevant category for our purposes.8
In March of 1995, the Equal Employment Opportunity Commission (EEOC)
issued interpretive guidance regarding the ADA that addressed the issue of genetic
discrimination.9 According to the EEOC, employers that discriminate against
individuals based upon genetic information are “regarding” the employees as having
a disability, and their acts of discrimination constitute violations of the ADA.10
Thus, according to the EEOC, employers who provide health insurance benefits to
their employees may not deny such benefits to individuals or charge them higher
premiums based upon genetic data.
Unfortunately, I think this might be a bit of a stretch, and the guidance has not
yet been tested in court. If an employer refuses to hire someone who tests positive
for BRCA1 or refuses to provide her with health insurance, the employer isn’t
regarding her as having a disability. Rather, the employer is regarding her only as
having a high likelihood of developing an illness at some time in the future. It
should also be noted that breast cancer is not necessarily a disability, according to the
courts. Some courts have ruled that it is a serious illness but not a “disability,”
especially if it goes into remission quickly after treatment with surgery or surgery
5
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Id. at § 902.8.
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and a short course of radiation therapy. Some genetic tests, therefore, will identify
susceptibilities to illness that are not necessarily disabilities covered by the ADA. It
is difficult to argue that an individual should benefit from statutory protection
stemming from a genetically-based prediction that she is likely to develop a disease,
even though she would not be covered by the ADA if she actually had the illness in
question. Consequently, I do not think that the EEOC’s interpretation of the ADA
will withstand judicial scrutiny.
There has been one case filed by the EEOC involving a challenge to genetic
testing under the ADA. On February 9, 2001, the EEOC sued Burlington North
Santa Fe Railroad, charging that the railroad violated the ADA by requiring
employees who filed claims for work-related carpal tunnel syndrome to provide
blood samples in order to determine whether they had a genetic susceptibility to the
condition. Presumably, if they were genetically susceptible to the disease, it would
not be a work-related injury, and the railroad would not have to pay the claim. On
February 12, 2001, the defendant announced that it would voluntarily stop
conducting the genetic tests, and the matter settled in April of 2001, so no court
opinion was issued in the case.
IV. EXECUTIVE ORDER
Federal employees enjoy stronger protection against genetic discrimination than
do most other Americans. On February 8, 2000, President Clinton issued Executive
Order No. 13145, “To Prohibit Discrimination in Federal Employment Based on
Genetic Information.” The executive order precludes federal employers from
requesting, requiring, collecting or purchasing genetic information from applicants
and employees. An exception to the general rule allows for the genetic testing of
applicants if the obtained information is to be used exclusively to determine whether
further evaluation is needed to diagnose a current medical condition that could
prevent the applicant from performing essential job functions. Only federal
employees are covered by the executive order.11
V. PROPOSED FEDERAL LEGISLATION
I have tried to show that neither state legislation nor existing federal law provides
comprehensive protection to the American public against genetic discrimination.
Consequently, if we are serious about addressing the issue, we will need new federal
legislation that will create a national mandate concerning genetic discrimination.
Numerous bills have in fact been introduced in Congress during the past few years,
though none has yet become law.
The first bill that Senator Thomas Daschle promoted after he became Minority
Leader in June of 2001 was his “Genetic Non-discrimination in Health Insurance and
Employment Act.”12 The bill would prohibit employers from using genetic
information in hiring new employees or in determining promotions, salary and

11

Exec. Order No. 13145, 65 Fed. Reg. 6877 (Feb. 8, 2000).

12

S. 318, 107th CONG. (2001).
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benefits.13 It would also bar all insurers from raising premiums or denying coverage
because of genetic test results.14
The Patient’s Bill of Rights that was passed by the Senate on June 29, 2001,
contained a last-minute amendment that would prohibit health insurers from
restricting enrollment or raising premium rates based on an individual’s genetic
information.15 In addition, President Bush pledged his support for banning genetic
discrimination by employers and insurers during a radio address in June, 2001.16
In light of the accomplishments of the Human Genome Project, the issue of
genetic discrimination has raised significant concern in academic and legislative
circles and has generated considerable media attention. Given the public’s repeated
and vocal cries for action, I think it is quite likely that Congress will pass an antidiscrimination mandate in the not too distant future.
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Id. at § 202(a)(1).
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Id. at § 104(a)(1)(E)(i).
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S. 1052, 107th CONG. § 122(b)(2).
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Remarks by the President in meeting with House Leaders on Patients’ Bill of Rights
(White House Radio Address, June 27, 2001).
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